Navigation Links
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
Date:7/15/2008

cal companies. Megapharm has demonstrated dynamic sales growth by developing a strong company presence and expertise in select therapeutic areas, and diversified segments of the healthcare business. The company also has a recognized and proven track record for obtaining reimbursement and inclusion of its products in all the health funds in Israel. For more information, visit http://www.megapharm.co.il.

Safe Harbor

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainty whether the clinical trial results will allow the company to complete submission of a New Drug Application and if a New Drug Application submission is completed, uncertainty whether FDA will file or approve such application, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials or differences of opinion in interpreting the results of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, the company's ability to timely regain its compliance with NASDAQ continued listing standards and maintain such compliance, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
5. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
6. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
7. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
(Date:2/26/2015)... 2015 Legislation passed today by the House ... help prevent inappropriate prescriptions in Medicare Part D from ... of Medicare Act (PIMA) of 2014 , introduced by ... (R-TX) and Ranking Member Jim McDermott (D-WA), recognizes ... and implement the right policies, said the Pharmaceutical Care ...
(Date:2/26/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) has ... - Global Strategic Business Report" report to their ... markets for Radiation Therapy Equipment in US$ Million by ... and Radiation Therapy Simulator. The report provides separate comprehensive ... Japan , Europe ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
... Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") announced ... dividend of $0.18 per share of common stock, which will ... as of November 30, 2009. The December 9, 2009 extraordinary ... to a plan of complete liquidation and dissolution and an ...
... , , WAYNE, Pa., Nov. 20 ... its fiscal first quarter ended September 30, 2009. ... decreased approximately $234,000, or 2.7%, to $8,435,000 during the three-month ... period last fiscal year. The Company reported the decreased ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7
(Date:2/27/2015)... Rafael, CA (PRWEB) February 27, 2015 The ... provide campers with newer facilities and to make camp more ... a better location for a Contact Football Camp. The fields ... the best in the country,” states Mike de Surville, vice ... our staff is comprised of experienced coaches with the passion ...
(Date:2/27/2015)... February 27, 2015 RDI-Engineering will be ... Pi Day event on March 14, at Moreno Valley ... demonstrations on how to use engineering software and tools, ... be hosted by Moreno Valley College’s Upward Bound Math ... Center (SSC) in hopes to encourage students to seek ...
(Date:2/27/2015)... 27, 2015 Is it reasonable – and ... practices and games, and possible to do so without causing ... sports might be at high risk for concern and could ... the issues being addressed by two introductory bills, Int. ... hearing last month in New York City. More specifically, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Many ... for people’s health. Mercola.com has introduced organic cotton ... contain toxic flame retardant chemicals. Dr. Mercola’s Healthy ... design and better materials. Organic cotton is significantly ... Mercola’s organic bedding products are made by Naturepedic ...
(Date:2/27/2015)... 2015 According to a Feb. 12, ... drug used to treat cancer by killing cancer stem cells, ... Drug Administration (FDA) for use in the treatment of mesothelioma.* ... the FDA to encourage the development of drugs for the ... about the FDA’s decision,” said Melinda Helbock, Founder of The ...
Breaking Medicine News(10 mins):Health News:US Sports Camps Football Camps Announce New Contact Football Camp Northeast Location 2Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3
... the deadly H5N1 strain of bird flu. Official sources, however, point ... spread of the virus is slow. , Nigeria, the ... reported any human cases, although experts warn that due to ineffective ... virus has now been reported in 14 of Nigeria's 36 states ...
... strides ahead with greater determination from obscurity to a global ... the pandemic// outpacing us, or are countries acting too slowly ... and affected another 40 million worldwide? ,In early ... the review meeting to the United Nations General Assembly's Special ...
... ITC Hotels on patisseries, Choco Fudge has been adjudged the ... ,The judges' panel consisted of eminent writers and fashion ... will take pride of place at all ITC hotels across ... ,Through the contest in Kolkata, ITC Hotels aims to ...
... the All India Institute of Medical Sciences has requested ... strict implementation of reservation// and end to 'victimisation' of ... ,Reacting to the gherao of the sub-dean of ... upon the President to exercise his moral authority and ...
... President of India wants the Government and people to ... and organ donation. In India., ,Inaugurating the blood ... Vice President asked the government and people to work in ... blood and organs must be encouraged to save precious lives, ...
... For severe COPD patients treated with budesonide added ... short acting bronchodilator, there is a reduced risk ... formoterol and/or terbutaline ,Important new data ... two pivotal Symbicort(R) studies, announced today at the ...
Cached Medicine News:Health News:AIDS: Why the pandemic outpaces us 2Health News:AIDS: Why the pandemic outpaces us 3Health News:Addition Of Budesonide To Formoterol Reduces Risk Of Mortality 2